Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Liu X, Chubak J, Hubbard RA, Chen Y SAT: a Surrogate-Assisted Two-wave case boosting sampling method, with application to EHR-based association studies 2022 Apr 13;29(5):918-927. doi: 10.1093/jamia/ocab267. Epub 2021-12-28. PubMed
Beatty JD, Sun Q, Markowitz D, Chubak J, Huang B, Etzioni R Identifying breast cancer recurrence histories via patient-reported outcomes 2022 Apr;16(2):388-396. doi: 10.1007/s11764-021-01033-7. Epub 2021-04-14. PubMed
Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial 2022 Apr;37(5):1073-1080. doi: 10.1007/s11606-021-06922-2. Epub 2021-05-28. PubMed
Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics 2022 Jan;154:106871. doi: 10.1016/j.ypmed.2021.106871. Epub 2021-11-08. PubMed
Zhu Y, Hubbard RA, Chubak J, Roy J, Mitra N Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches 2021 Nov;30(11):1471-1485. doi: 10.1002/pds.5338. Epub 2021-08-10. PubMed
Hubbard RA, Lett E, Ho GYF, Chubak J Characterizing Bias Due to Differential Exposure Ascertainment in Electronic Health Record Data 2021 Sep;21(3):309-323. doi: 10.1007/s10742-020-00235-3. Epub 2021-01-04. PubMed
Chubak J, Hawkes R, Dudzik C, Ziebell RA, Sherman KJ Letter: The Choice of Control Conditions in Animal-Assisted Intervention Research 2021 Jan;20:15347354211025626. doi: 10.1177/15347354211025626. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.